- /
- Supported exchanges
- / US
- / AHKSY.PINK
Asahi Kaisei Corp (AHKSY PINK) stock market data APIs
Asahi Kaisei Corp Financial Data Overview
Asahi Kasei Corporation engages in material, homes, healthcare businesses. The company offers Pimel photosensitive polyimide/PBO precursor, a liquid photosensitive material for buffer coating and packaging applications; Sunfort dry film photoresist to form circuit patterns on printed wiring boards; Novacure, a latent curing agent for epoxy resin with storage stability; glass fabric for printed circuit boards; plastic optical fiber; suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; Hipore, a microporous polyolefin sheet which prevents the anode and cathode from contacting one another; Celgard, a lithium-ion battery separator; Deramic, a lead acid battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, ROICA, ELTAS, Bemliese, EUTEC, Precisé, SEMIA, smash, PULSHUT, Lastan, Cubit, NanoAct, ECORISE, BioCradle, CMC-Bemliese names. It also provides cling film, bags and containers, and dishwashing liquid under the Saran Wrap, Ziploc, Cookper, Frosch names; packaging products under the OPS, Suntec, Barrialon, PVDC latex, and Saran names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company is involved in the provision of remodeling services; real estate-related operations; offers unit homes and apartment buildings; autoclaved aerated concrete, foundation systems, thermal insulation, and structural systems and components products; prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; enzymes and diagnostic products; and hemodialysis, therapeutic apheresis, and autologous blood-related businesses. The company was founded in 1922 and is headquartered in Tokyo, Japan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Asahi Kaisei Corp data using free add-ons & libraries
Get Asahi Kaisei Corp Fundamental Data
Asahi Kaisei Corp Fundamental data includes:
- Net Revenue: 3 033 346 M
- EBITDA: 403 464 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-29
- EPS/Forecast: 0.3691
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Asahi Kaisei Corp News
New
Asahi Kasei Wins BioTech Breakthrough Award for Planova™ FG1 Filter
Planova FG1 Filter CHELMSFORD, Mass. & TOKYO, November 13, 2025--(BUSINESS WIRE)--Asahi Kasei Corporation has earned top honors in the 2025 BioTech Breakthrough Awards, winning the Biomanufacturing I...
Asahi Kasei Microdevices Showcases AgeTech and PetTech Solutions Combining Privacy and Convenience at CES® 2026
Mockup of Asahi Kasei Microdevices' booth at CES 2026, focusing on AgeTech and PetTech Sensing technologies enhance the health and safety of people and pets TOKYO, November 12, 2025--(BUSINESS WIRE)...
Calliditas Therapeutics Reports Safety Data for Setanaxib in Patients with Alport Syndrome at the American Society of Nephrology Kidney Week
STOCKHOLM, Nov. 10, 2025 /PRNewswire/ -- Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that primary safety endpoints of a Phase 2a, randomized, double-blind, placebo-co...
Asahi Kasei (TSE:3407) Margin Gains Reinforce Bullish Narratives After Five-Year Earnings Decline Reversal
Asahi Kasei (TSE:3407) reported net profit margins of 4%, up from 2.4% last year. Earnings growth over the past year reached a stellar 76.6%. Looking ahead, management is guiding for 13.28% earnings g...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.